A citation-based method for searching scientific literature

Ye Young Seo, Ie Ryung Yoo, Sonya Youngju Park, Jin Kyoung Oh, Sung Hoon Kim, Hyung Sun Sohn. Breast Cancer 2017
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation.
L J Solin, B L Fowble, I T Yeh, M J Kowalyshyn, D J Schultz, M C Weiss, R L Goodman. Int J Radiat Oncol Biol Phys 1992
69
33

Significance of micrometastases on the survival of women with T1 breast cancer.
Douglas C Maibenco, George W Dombi, Tsui Y Kau, Richard K Severson. Cancer 2006
30
33

Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Eileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, Wedad Hanna, Deva Thiruchelvam, Refik Saskin, Carole Taylor, Alan Tuck, Sandip Sengupta, Leela Elavathil,[...]. Breast Cancer Res Treat 2013
39
33

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Rahul R Parikh, Bruce G Haffty, Donald Lannin, Meena S Moran. Int J Radiat Oncol Biol Phys 2012
50
33

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Eleftherios P Mamounas, Gong Tang, Bernard Fisher, Soonmyung Paik, Steven Shak, Joseph P Costantino, Drew Watson, Charles E Geyer, D Lawrence Wickerham, Norman Wolmark. J Clin Oncol 2010
379
33

Pathological assessment of microinvasive carcinoma of the breast.
Miki Mori, Koichiro Tsugawa, Hideko Yamauchi, Hiroshi Yagata, Koyu Suzuki, Sachiko Ohde, Kumiko Soejima, Seigo Nakamura. Breast Cancer 2013
15
33


Microinvasive carcinoma of the breast.
Simonetta Bianchi, Vania Vezzosi. Pathol Oncol Res 2008
52
33

Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Hye Mi Kim, Michael Goodman, Brian I Kim, Kevin C Ward. J Registry Manag 2011
11
33

Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Danielle N Margalit, Meera Sreedhara, Yu-Hui Chen, Paul J Catalano, Paul L Nguyen, Mehra Golshan, Beth A Overmoyer, Jay R Harris, Jane E Brock. Ann Surg Oncol 2013
31
33

Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.
Eileen Rakovitch, Steven A Narod, Sharon Nofech-Moses, Wedad Hanna, Deva Thiruchelvam, Refik Saskin, Carole Taylor, Alan Tuck, Bruce Youngson, Naomi Miller,[...]. Int J Radiat Oncol Biol Phys 2013
25
33

Ductal carcinoma in situ with microinvasion.
Tara L Adamovich, Rache M Simmons. Am J Surg 2003
47
33

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Mahul B Amin, Frederick L Greene, Stephen B Edge, Carolyn C Compton, Jeffrey E Gershenwald, Robert K Brookland, Laura Meyer, Donna M Gress, David R Byrd, David P Winchester. CA Cancer J Clin 2017
33

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Ke-Da Yu, La-Mu Wu, Guang-Yu Liu, Jiong Wu, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao. Ann Surg Oncol 2011
47
33

Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Cindy B Matsen, Allison Hirsch, Anne Eaton, Michelle Stempel, Alexandra Heerdt, Kimberly J Van Zee, Hiram S Cody, Monica Morrow, George Plitas. Ann Surg Oncol 2014
27
33

Predictors of microinvasion and its prognostic role in ductal carcinoma in situ.
Gloria R Sue, Donald R Lannin, Brigid Killelea, Anees B Chagpar. Am J Surg 2013
23
33

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
Isabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Isabelle Soubeyran, Véronique Picot, Jean-Michel Coindre. Cancer 2002
78
33

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Paul L Nguyen, Alphonse G Taghian, Matthew S Katz, Andrzej Niemierko, Rita F Abi Raad, Whitney L Boon, Jennifer R Bellon, Julia S Wong, Barbara L Smith, Jay R Harris. J Clin Oncol 2008
580
33

Breast cancer subtypes and the risk of local and regional relapse.
K David Voduc, Maggie C U Cheang, Scott Tyldesley, Karen Gelmon, Torsten O Nielsen, Hagen Kennecke. J Clin Oncol 2010
820
33

Cancer recurrence: an important but missing variable in national cancer registries.
Haejin In, Karl Y Bilimoria, Andrew K Stewart, Kristen E Wroblewski, Mitchell C Posner, Mark S Talamonti, David P Winchester. Ann Surg Oncol 2014
63
33

Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Almir G V Bitencourt, Eduardo N P Lima, Bruna R C Macedo, Jorge L F A Conrado, Elvira F Marques, Rubens Chojniak. Eur Radiol 2017
7
33

Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Asako Azuma, Mitsuhiro Tozaki, Kensuke Ito, Eisuke Fukuma, Tomoko Tanaka, Toshihiro O'uchi. Radiat Med 2008
11
33

[Photochemical reduction of chlorophyll analogs by tryptophan].
A V Umrikhina, A A Krasnovskiĭ. Biokhimiia 1969
1
100

In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.
M Blichert-Toft, H P Graversen, J Andersen, U Dyreborg, A Green. World J Surg 1988
20
33



Effect of retained components of excised tumor upon coexisting tumor.
K Arai, H W Wallace, T Asakura, P Nemir. J Surg Res 1989
2
50

Genetic predisposition to ductal carcinoma in situ of the breast.
Christos Petridis, Mark N Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, Dina Levi, Efterpi Papouli, Nick Orr, Angela Cox,[...]. Breast Cancer Res 2016
29
33

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
187
33

Ten-year follow-up of breast carcinoma in situ in Connecticut.
B A Ward, C F McKhann, T S Ravikumar. Arch Surg 1992
29
33


Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies.
D Delia, C Traversari, D Ballinari, G Cattoretti, E Fontanella, N Polli, G Della Porta. Immunology 1988
14
33

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
887
33

Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer.
Naohiro Taira, Eriko Atsumi, Saori Nakachi, Reika Takamatsu, Tomofumi Yohena, Hidenori Kawasaki, Tsutomu Kawabata, Naoki Yoshimi. Lung Cancer 2018
9
33



Molecular evolution of breast cancer.
Peter T Simpson, Jorge S Reis-Filho, Theodora Gale, Sunil R Lakhani. J Pathol 2005
338
33


Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
353
33

Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study.
Tomoyuki Fujioka, Kazunori Kubota, Akira Toriihara, Youichi Machida, Kaori Okazawa, Tsuyoshi Nakagawa, Yukihisa Saida, Ukihide Tateishi. World J Radiol 2016
9
33

Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Suzana C Teixeira, José Ferrér Rebolleda, Bas B Koolen, Jelle Wesseling, Raúl Sánchez Jurado, Marcel P M Stokkel, María Del Puig Cózar Santiago, Vincent van der Noort, Emiel J Th Rutgers, Renato A Valdés Olmos. AJR Am J Roentgenol 2016
20
33

First clinical experience with a dedicated PET for hanging breast molecular imaging.
B B Koolen, T S Aukema, A J González Martínez, W V Vogel, L Caballero Ontanaya, M J Vrancken Peeters, C J J Vroonland, E J Rutgers, J M Benlloch Baviera, R A Valdés Olmos. Q J Nucl Med Mol Imaging 2013
14
33

Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Heba Hussein, Caroline Chung, Hadas Moshonov, Naomi Miller, Supriya R Kulkarni, Anabel M Scaranelo. Acad Radiol 2015
11
33


Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
K Han, S Nofech-Mozes, S Narod, W Hanna, D Vesprini, R Saskin, C Taylor, I Kong, L Paszat, E Rakovitch. Clin Oncol (R Coll Radiol) 2012
34
33

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
33

[A new case report of J-Baltimore hemoglobinopathy in a diabetic caucasian].
L Meyer, V Durlach, F X Maquart, P Gillery, H Grulet, M Leutenegger. Rev Med Interne 1992
2
50

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
184
33

Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.
D Rosner, R N Bedwani, J Vana, H W Baker, G P Murphy. Ann Surg 1980
256
33

Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
R S Brown, J Y Leung, S J Fisher, K A Frey, S P Ethier, R L Wahl. J Nucl Med 1996
114
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.